Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction (Q35208151)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction |
scientific article |
Statements
1 reference
Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction (English)
1 reference
Z A Wainberg
1 reference
L-S Lin
1 reference
B DiCarlo
1 reference
K M Dao
1 reference
R Patel
1 reference
D J Park
1 reference
H-J Wang
1 reference
R Elashoff
1 reference
N Ryba
1 reference
J R Hecht
1 reference
2 August 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference